Assistive, Neurostim Devices Get 'Patient Preference' Attention From US FDA
Executive Summary
The agency's patient-preference initiative is expanding with a new workshop that will unite FDA lab staff and patients to discuss patient perspectives on assistive and neurological stimulation devices.